NeuroTransData, a network of physicians from Germany, has been instrumental in the implementation of a highly accurate and sophisticated recommender system for the treatment of multiple sclerosis. PHREND is an application that allows physicians to predict the efficacy of MS treatments on the basis of historical data. In collaboration with doctors and patients and by using a human-centred design approach, the technology was built to be perfectly integrated in the patient/doctor dialogue. The AI-assisted algorithm instantly analyses patient data to predict MS treatment. The tool has won multiple awards and is widely accepted in the medical community. Statistics show that the personalised healthcare solution PHREND enables more effective treatment of MS.¨